Skip to content
★ Sign in to follow
DO

D Owen

CEO
GlaxoSmithKline plc
Total declarations
3
Company
1
▲ Purchases (0 ops.)
—
▼ Sales (1 ops.)
€1.1M

Latest filing published 16 Dec 2016 for GlaxoSmithKline plc.

Insider track record

Disclosed buys
0
Disclosed sells
1
Signal history

No signal scores available.

D Owen: trading record in brief

D Owen appears in our data through filings on GlaxoSmithKline plc shares, published by RNS (LSE). In total, 3 filings cover trades dated from 28 October 2016 to 15 December 2016.

Every open-market trade on record is a sale: 1 sale worth €1.1M.

Most recently, on 16 December 2016, the filings show a transaction in GlaxoSmithKline plc. Half of the filings or more reach the RNS (LSE) feed on the day of the trade. The regulation allows three business days to notify a trade (UK MAR). Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. Source: insider filings from RNS (LSE). Past trades are no guide to future returns.

Companies and markets linked to D Owen

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations3 total
  • ●
    PCA of Ms E Walmsley (CEO Designate)ExecutivesGlaxoSmithKline plc
    0FCA-NSM
    17,849 sharesn/aISIN GB0009252882FCA-NSM:LSE20161216104558_013069964_20200330143549253_12468-1
  • ●
    PCA of Ms E Walmsley (CEO Designate)ExecutivesGlaxoSmithKline plc
    0FCA-NSM
    60,000 sharesn/aISIN GB0009252882FCA-NSM:LSE20161028141735_013017056_20200330143616807_21902-1
  • ▼
    PCA of Ms E Walmsley (CEO Designate)ExecutivesGlaxoSmithKline plc
    987,018 GBP45FCA-NSM
    60,000 shares@ £16.4503100.0% of flowLondon Stock Exchange (XLON)ISIN GB0009252882FCA-NSM:LSE20161028141735_013017056_20200330143616807_21902-3

3 of 3 declarations